Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hematologic Neoplasms 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Lymphoma, Non-Hodgkin 12Myeloproliferative Disorders 11Lymphoma 11Leukemia, Myelomonocytic, Chronic 11Graft vs Host Disease 10Primary Myelofibrosis 9Leukemia 9Hodgkin Disease 9Leukemia, Lymphocytic, Chronic, B-Cell 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 5Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Anemia, Aplastic 4Thrombocythemia, Essential 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Neoplasms, Plasma Cell 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoproliferative Disorders 3

Interventions

Cyclophosphamide 12Specimen Handling 9cabozantinib 8X-Rays 8Magnetic Resonance Spectroscopy 8fludarabine 7Phantoms, Imaging 7Biopsy 7Temozolomide 6Gemcitabine 5regorafenib 4pembrolizumab 4Vincristine 4Nuclear Medicine Department, Hospital 4Nivolumab 4Methotrexate 4Doxorubicin 4olaparib 3irinotecan sucrosofate 3fludarabine phosphate 3dinutuximab 3Zoledronic Acid 3Surveys and Questionnaires 3Irinotecan 3Ifosfamide 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Tacrolimus × 1 year × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡